Literature DB >> 13628933

Hageman trait and PTA deficiency; the role of contact of blood with glass.

J P SOULIER, O WARTELLE, D MENACHE.   

Abstract

Entities:  

Keywords:  HEMOPHILIA

Mesh：

Year:  1959        PMID： 13628933     DOI： 10.1111/j.1365-2141.1959.tb04017.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  8 in total

1.  THE INDUCTION OF PERMEABILITY-INCREASING ACTIVITY IN HUMAN PLASMA BY ACTIVATED HAGEMAN FACTOR.

Authors:  O D RATNOFF; A A MILES
Journal:  Br J Exp Pathol       Date:  1964-06

2.  The nature of the coagulation defect in rats fed diets which produce thrombosis or experimental atherosclerosis.

Authors:  E DAVIDSON; A N HOWARD; G A GRESHAM
Journal:  Br J Exp Pathol       Date:  1962-04

3.  Studies on the action of Hageman factor: evidence that activated Hageman factor in turn activates plasma thromboplastin antecedent.

Authors:  O D RATNOFF; E W DAVIE; D L MALLETT
Journal:  J Clin Invest       Date:  1961-05       Impact factor: 14.808

4.  [Blood platelets and coagulationactive plasma proteins. A short summary of their function and pathology].

Authors:  E MAMMEN; R GROSS
Journal:  Blut       Date:  1962-05

Review 5.  The effects of bacterial endotoxins on host mediation systems. A review.

Authors:  D C Morrison; R J Ulevitch
Journal:  Am J Pathol       Date:  1978-11       Impact factor: 4.307

6.  Factor XI contributes to thrombin generation in the absence of factor XII.

Authors:  Dmitri V Kravtsov; Anton Matafonov; Erik I Tucker; Mao-Fu Sun; Peter N Walsh; Andras Gruber; David Gailani
Journal:  Blood       Date:  2009-04-07       Impact factor: 22.113

7.  Evolution of the contact phase of vertebrate blood coagulation.

Authors:  M B Ponczek; D Gailani; R F Doolittle
Journal:  J Thromb Haemost       Date:  2008-08-28       Impact factor: 5.824

8.  Inhibition of Hageman factor activation.

Authors:  H L Nossel; H Rubin; M Drillings; R Hsieh
Journal:  J Clin Invest       Date:  1968-05       Impact factor: 14.808
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.